Praveen B Raju, MD, PhD

img_Praveen B Raju
ADJUNCT ASSOCIATE PROFESSOR | Neurology
Pediatric Brain Tumors
Dr. Raju directs the Laboratory for Pediatric Brain Tumor Research at ISMMS and studies the developmental origins of pediatric brain tumors with a particular focus on medulloblastoma and its relationship to developmental signal transduction pathways. Through the utilization of sophisticated mouse genetics techniques, Dr. Raju and his team are creating new and improved preclinical mouse models of these childhood brain tumors to better understand their biology, investigate novel treatment approaches, as well as identify treatment resistance mechanisms that can be translated back for use in patients in order to improve their outcomes. Dr. Raju's research program has received support from the NIH/NINDS, NIH/NICHD, Department of Defense (DOD), STARR Cancer Consortium, St. Baldrick's Foundation for Childhood Cancer, Hartwell Foundation for Pediatric Research, American Brain Tumor Association, Unravel Pediatric Cancer Foundation, Hyundai Hope on Wheels Foundation, and Alex's Lemonade Stand Foundation for Childhood Cancer Research.

2016

Innovation Award

Alex's Lemonade Stand Foundation

2015

Hope Scholar

Hyundai Hope on Wheels Foundation

2012

Hartwell Investigator

The Hartwell Foundation

2011

Caryl & Israel A. Englander Clinical Scholar in Children’s Health

Weill-Cornell Medical College

2006

George Von L. Meyer Award

Boston Children's Hospital

Pediatric Neurology Program

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Raju during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Founder/Co-Founder/Partner

  • Selectin Therapeutics, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.